Table 3.
Skin roughness (R1) |
Maximum roughness (R2) |
Average roughness (R3) |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
GC | Placebo | p1) | p2) | GC | Placebo | p1) | p2) | GC | Placebo | p1) | p2) | |
Baseline | 0.14 ± 0.03 | 0.14 ± 0.05 | 0.09 ± 0.02 | 0.08 ± 0.03 | 0.06 ± 0.01 | 0.06 ± 0.02 | ||||||
After 4 wks | 0.13 ± 0.03 | 0.13 ± 0.05 | 0.291 | 0.407 | 0.08 ± 0.02 | 0.08 ± 0.03 | 0.833 | 0.216 | 0.05 ± 0.01 | 0.06 ± 0.02 | 0.968 | 0.478 |
Difference3) | −0.01 ± 0.04 | 0.00 ± 0.03 | 0.011* | −0.01 ± 0.02 | 0.00 ± 0.02 | 0.005** | 0.00 ± 0.01 | 0.00 ± 0.01 | 0.004** | |||
p4) | 0.008** | 0.007** | 0.005** | 0.004** | 0.003** | 0.003** | ||||||
After 8 wks | 0.12 ± 0.03 | 0.12 ± 0.06 | 0.265 | 0.859 | 0.07 ± 0.02 | 0.07 ± 0.04 | 0.272 | 0.579 | 0.05 ± 0.01 | 0.05 ± 0.02 | 0.645 | 0.828 |
Difference5) | −0.02 ± 0.04 | −0.02 ± 0.04 | 0.011* | −0.01 ± 0.02 | −0.01 ± 0.03 | 0.007** | −0.01 ± 0.01 | −0.01 ± 0.012 | 0.005** | |||
p4) | 0.007** | 0.009** | 0.004** | 0.006** | 0.003** | 0.003* | ||||||
After 12 wks | 0.11 ± 0.03 | 0.14 ± 0.06 | 0.693 | 0.015* | 0.07 ± 0.01 | 0.08 ± 0.03 | 0.844 | 0.044* | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.270 | 0.022* |
Difference6) | −0.03 ± 0.04 | 0.00 ± 0.04 | 0.012* | −0.02 ± 0.02 | 0.00 ± 0.02 | 0.007** | −0.01 ± 0.01 | 0.00 ± 0.02 | 0.004** | |||
p4) | 0.008* | 0.009** | 0.005** | 0.005** | 0.003** | 0.004** |
Smoothness depth (R4) |
Arithmetic average (R5) |
|||||||
---|---|---|---|---|---|---|---|---|
GC | Placebo | p1) | p2) | GC | Placebo | p1) | p2) | |
Baseline | 0.07 ± 0.02 | 0.07 ± 0.02 | 0.02 ± 0.01 | 0.03 ± 0.01 | ||||
After 4 wks | 0.06 ± 0.02 | 0.06 ± 0.02 | 0.574 | 0.359 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.397 | 0.650 |
Difference3) | −0.01 ± 0.02 | 0.00 ± 0.02 | 0.006** | 0.00 ± 0.01 | 0.00 ± 0.01 | 0.003** | ||
p4) | 0.005** | 0.004** | 0.003** | 0.002** | ||||
After 8 wks | 0.06 ± 0.02 | 0.06 ± 0.03 | 0.279 | 1.000 | 0.02 ± 0.01 | 0.02 ± 0.02 | 0.386 | 0.748* |
Difference5) | −0.01 ± 0.02 | −0.01 ± 0.02 | 0.006** | 0.00 ± 0.01 | 0.00 ± 0.01 | 0.003** | ||
p4) | 0.003** | 0.005* | 0.002** | 0.002** | ||||
After 12 wks | 0.06 ± 0.02 | 0.07 ± 0.03 | 0.955 | 0.034* | 0.02 ± 0.01 | 0.03 ± 0.02 | 0.920 | 0.065* |
Difference6) | −0.01 ± 0.02 | 0.00 ± 0.02 | 0.007** | −0.00 ± 0.01 | 0.00 ± 0.01 | 0.003** | ||
p4) | 0.005** | 0.005** | 0.002** | 0.002** |
*p < 0.05, **p < 0.01 by Student t test for comparison with placebo group.
GC, mixture of Panax ginseng and Crataegus pinnatifida.
Compared between groups: p value by Student t test.
Compared between groups: p value by analysis of covariance (adjustment with baseline).
After 8 wks – baseline.
Compared within groups: p value by paired t test.
After 16 wks – baseline.
After 24 wks – baseline.